The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.00
Change: -0.50 (-0.45%)
Spread: 0.50 (0.457%)
Open: 114.50
High: 114.50
Low: 110.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amended Financing Agreement

29 Sep 2022 11:51

RNS Number : 1923B
McBride PLC
29 September 2022
 

29 September 2022

 

McBride plc

 

Amended Financing Agreement

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today announces the agreement of amendments to the Group's financing agreements.

In summary, the Group's €175m sustainability-linked revolving credit facility (RCF) remains in place to its original maturity date of May 2026. However, there will be no covenant tests until September 2024, other than a liquidity limit which has been reduced to £15m from the £40m in place since our first covenant waiver in December 2021. As part of this arrangement, the lender group has been granted a security package over assets and investments and there is a modest and progressive step down in the RCF commitment from September 2024. Additionally, the invoice discounting lines, totalling £83m, have been extended and committed to September 2024. More detail on these amendments is set out below.

These financing agreements provide a firm funding platform permitting the Group to further progress its Compass ambitions, as outlined in February 2021. The Group would like to express its thanks for the support that the lender group has given to the Group both through this recent period of uncertainty and in the amendment of our agreements.

The key provisions of the revised agreement are:

€175m sustainability-linked revolving credit facility

· This is reconfirmed to May 2026 (no change from current agreement)

· The RCF is to be secured against material assets, shares and inter-company balances, subject to a mutual agreement to review the continuing requirement for security once the Group is in compliance with the financial covenants below

· Commitments to reduce (and be cancelled) in the amount of the euro equivalent of £2.5m every three months from September 2024 up until the maturity date.

Existing bilateral overdraft facilities with the lender group

· Overdrafts of £5m and €15m shall become ancillary facilities under the RCF, committed until 30 September 2024

Invoice discounting facilities

· Committed to 30 September 2024

Covenants:

· Liquidity

shall not be less than £15m on or prior to 30 September 2024

shall not be less than £25m post 30 September 2024

· Net debt cover

to be tested quarterly from 30 September 2024

shall not exceed 3:1 for 30 September 2024 and 31 December 2024

shall not exceed 2.75:1 thereafter

· Interest cover

to be tested quarterly from 30 September 2024

to be no less than 3.4:1 for 30 September 2024

to be no less than 3.9:1 for 31 December 2024

to be no less than 4:1 for 31 March 2025 and 30 June 2025

to be no less than 4.25:1 thereafter

· No dividends will be paid to shareholders until the RCF is refinanced (at maturity or earlier)

Pricing and fees:

· No increase in margin applicable to borrowings when debt cover 2.5x or lower

· When debt cover 2.5x or higher, margin applicable to borrowings rises by 35-235 bps depending on debt cover level

· The arrangement includes an 'upside sharing' mechanism whereby, subject to certain exceptions, a fee will become payable by the Group to members of the lending group upon the occurrence of an exit event (e.g., change of control of the Group or a prepayment or repayment in full of the facility). The fee will equate to 11% of any increase from the current market capitalisation of the Group to the market capitalisation of the Group at the date of the exit event (subject to deductions for any increase to market capitalisation relating to certain share issues).

The Group considers that the arrangement achieves an appropriate balance between the interests of all stakeholders of the Group. In particular, we have been in regular discussion and consultation with the Trustee of the Group's defined benefit pension scheme in the UK. In order to preserve and support the position of the scheme, with the support of the lender group, we have agreed to provide in favour of the scheme a package of additional credit support in the UK, as well as a new information sharing protocol to ensure ongoing communication between the Group and the Trustee remains comprehensive.

 

Commenting, Mark Strickland, CFO, said:

"This reset of our financing agreements is the culmination of detailed reviews of the business prospects by the Board, its financial advisors and the lender group, and is an excellent outcome following the very difficult trading period over the past 12 to 18 months. It provides the business with funding certainty as our trading prospects recover and we refocus our teams on the improvements anticipated through the Compass strategies."

 

For further information, please contact:

McBride plc

 

Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Financial Officer

0161 203 7570

FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUUABUPPGUB
Date   Source Headline
10th Jan 20197:00 amRNSTrading Update
4th Dec 20183:26 pmRNSIssue of B Shares
3rd Dec 20184:15 pmRNSIssue of B Shares
19th Nov 20187:00 amRNSCompletion of Disposal
31st Oct 20182:40 pmRNSHolding(s) in Company
24th Oct 20184:21 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Trading Update
16th Oct 201812:52 pmRNSHolding(s) in Company
16th Oct 201812:51 pmRNSHolding(s) in Company
12th Oct 20184:48 pmRNSHolding(s) in Company
21st Sep 20183:59 pmRNSAnnual Financial Report and Notice of AGM
14th Sep 20184:09 pmRNSTotal Voting Rights
13th Sep 20185:01 pmRNSDirector/PDMR Shareholding
12th Sep 20184:33 pmRNSNotification and public disclosure of LTIP
12th Sep 20183:49 pmRNSHolding(s) in Company
6th Sep 20187:00 amRNSFinal Results
13th Aug 20184:20 pmRNSHolding(s) in Company
7th Aug 20181:24 pmRNSHolding(s) in Company
3rd Aug 20182:03 pmRNSHolding(s) in Company
10th Jul 20189:12 amRNSHolding(s) in Company
6th Jul 20183:42 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
3rd Jul 20187:00 amRNSSale of European Personal Care liquids
5th Jun 20185:10 pmRNSHolding(s) in Company
5th Jun 201810:24 amRNSIssue of Equity
27th Apr 201812:45 pmRNSHolding(s) in Company
15th Mar 20185:33 pmRNSTR1 - Notification of Major Holdings
12th Mar 20184:54 pmRNSNotification of Major Holdings
2nd Mar 20183:27 pmRNSNotification of Major Holdings
27th Feb 20185:02 pmRNSTotal Voting Rights
27th Feb 20185:02 pmRNSNotification and public disclosure of LTIP
22nd Feb 20187:00 amRNSHalf-year Report
13th Feb 20184:52 pmRNSHolding(s) in Company
11th Jan 20183:50 pmRNSHolding(s) in Company
8th Jan 20187:00 amRNSTrading Update
4th Dec 20174:55 pmRNSIssue of B Shares
16th Nov 201710:40 amRNSHolding(s) in Company
13th Nov 20179:12 amRNSHolding(s) in Company
10th Nov 201710:31 amRNSHolding(s) in Company
25th Oct 20174:35 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20172:30 pmRNSInvestor Day and Site Visits
29th Sep 201712:00 pmRNSCompletion of the acquisition of Danlind a/s
22nd Sep 20174:11 pmRNSAnnual Report and Accounts
22nd Sep 20171:43 pmRNSHolding(s) in Company
13th Sep 20174:00 pmRNSHolding(s) in Company
13th Sep 20172:30 pmRNSDirector/PDMR Shareholding
12th Sep 20174:27 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSAcquisition of Danlind a/s

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.